Sofia was eight months old when her family, living in the Ialoveni district outside Chișinău, received the diagnosis: cystic fibrosis, a rare genetic disease with no cure and, in Moldova, very few of the tools that make it manageable elsewhere. For her mother, the early months were disorienting — grappling with a diagnosis that carried a lifetime of implications, learning a body of medical knowledge most parents never need, and coming to terms with a level of responsibility few are prepared for.

Eight years later, that responsibility has become routine, if never easy. Sofia's day is structured around inhalation therapy and physiotherapy sessions, and every meal requires enzyme supplements dosed against the precise fat content of what she eats. Her environment has to be tightly controlled — surfaces disinfected, contact limited to family members who are confirmed healthy — because for a child with CF, an ordinary cold can mean a hospital stay. None of this is optional, and none of it pauses.

What makes Sofia's situation especially difficult is a gap that donors familiar with global health disparities will recognize immediately: the CFTR modulator therapies that have transformed CF care in North America and Western Europe over the past decade — drugs that treat the disease at its genetic root rather than just managing symptoms — are largely unavailable in Moldova. Families like Sofia's are left managing a disease with 1990s-era tools while knowing that better treatment exists, just out of reach because of geography and healthcare infrastructure rather than medicine.

Sofia's mother describes the discipline of caregiving as something that has reshaped her — she has become more organized, more informed, and more resilient than she ever expected to be, sustained by her husband's steady support and the couple's shared determination not to let the disease define their family. Her hope for Sofia is straightforward: a future where the coughing stops, where enzymes and inhalers are no longer a daily necessity, and where her daughter can simply live — not manage a condition, just live.

For organizations like ANIFC, and for MEF as a supporting partner, stories like Sofia's are the reason access — to medication, to equipment, to basic respiratory care — remains urgent. Sofia is one of a small but real population of Moldovan children whose quality of life depends on resources that, elsewhere, are considered standard of care.

Read the family's full story on ANIFC's website →